Comparative Management of Sheetpitta With Ayurvedic and Allopathic Drug

"Comparative Study of efficacy of Amrutadi Kwath and Tablet Loratidine in Sheetpitta with special reference to Urticaria

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024171

Enrollment

Registered

2020-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R21- Rash and other nonspecific skin eruption

Interventions

Intervention1: Amrutadi Kwath: 20 ml of amrutadi kwath thrice a day with koshna jala for 45 dayswill relives the symptom of sheetpitta Control Intervention1: loratidine: loratidine 10mg once a day wit

Eligibility

Inclusion criteria

Inclusion criteria: patient having symptoms of varatidast samsthana shotha and kandu.

Exclusion criteria

Exclusion criteria: known case of diabetes mellitus. urticarial associated with other skin disease patient having insect bite urticarial. patient who is already on any kind of medication.

Design outcomes

Primary

Measure	Time frame
relief from classical symptom of sheetpittaTimepoint: 45 days	—

Secondary

Measure	Time frame
relief in hives and itching and non reoccurrence of diseaseTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Jaya Gupta

DMIMS DU

vkuchewar@gmail.com9420998747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026